Biomarkers in the Diagnosis of Alzheimer’s Disease: Are We Ready?
Authors:
- 1 September 2006
- journal article
- research article
- Published by SAGE Publications in Journal of Geriatric Psychiatry and Neurology
- Vol. 19 (3) , 172-179
Abstract
Although clinical manifestations of cognitive dysfunction and impairments of activities of daily living are the current standard measures for the diagnosis of Alzheimer’s disease, biomarkers are receiving increasing attention in research centers as possible early diagnostic measures or as surrogate measures of the ongoing pathology. In preparation for the upcoming development of the Diagnostic and Statistical Manual of Mental Disorders (5th ed; DSM-V) nosology, the American Psychiatric Association has sponsored an effort to reassess the current approaches to diagnosis in dementia in general and Alzheimer’s disease in particular. This article focuses on the potential use of biomarkers in the diagnosis of Alzheimer’s disease, in the monitoring of mild cognitive impairment, and as possible prognostic markers in normal controls at risk for dementia. Most advanced information is available with the biomarkers found in the cerebrospinal fluid, but there are many other potential biomarkers using blood, brain imaging, or a combination. The current biomarker approaches to diagnosis are reviewed along with a special emphasis on near-term recommendations and further research directions. (J Geriatr Psychiatry Neurol 2006;19:172-179)Keywords
This publication has 78 references indexed in Scilit:
- Comparison of clinical and neuropathologic diagnoses of Alzheimer's disease in 3 epidemiologic samplesAlzheimer's & Dementia, 2006
- Prognostic Factors in Advanced Cancer Patients: Evidence-Based Clinical Recommendations—A Study by the Steering Committee of the European Association for Palliative CareJournal of Clinical Oncology, 2005
- The Use of Biomarkers in the Elderly: Current and Future ChallengesBiological Psychiatry, 2005
- CSF Total tau, Aβ42 and Phosphorylated tau Protein as Biomarkers for Alzheimer's DiseaseMolecular Neurobiology, 2001
- Early Detection of Alzheimer's Disease by Combining Apolipoprotein E and NeuroimagingaAnnals of the New York Academy of Sciences, 1996
- Tau in cerebrospinal fluid: A potential diagnostic marker in Alzheimer's diseaseAnnals of Neurology, 1995
- A Potential Noninvasive Neurobiological Test for Alzheimer's DiseaseScience, 1994
- Clinically Diagnosed Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 1992
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)Neurology, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984